Literature DB >> 24054125

Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection.

Tommaso Lomonaco1, Silvia Ghimenti, Isabella Piga, Massimo Onor, Bernardo Melai, Roger Fuoco, Fabio Di Francesco.   

Abstract

Two analytical procedures are presented for the determination of the total content and unbound fraction of both warfarin and warfarin alcohols in human plasma. Chromatographic separation was carried out in isocratic conditions at 25°C on a C-18 reversed-phase column with a mobile phase consisting of a 70% buffer phosphate 25mM at pH=7, 25% methanol and 5% acetonitrile at a flow rate of 1.2mL/min. Fluorescence detection was performed at 390nm (excitation wavelength 310nm). Neither method showed any detectable interference or matrix effect. Inter-day recovery of the total warfarin and warfarin alcohols at a concentration level of 1000ng/mL was 89±3% and 73±3%, respectively, whereas for their unbound fraction (at a concentration level of 10ng/mL) was 66±8% and 90±7%, respectively. The intra- and inter-day precision (assessed as relative standard deviation) was <10% for both methods. The limits of detection were 0.4 and 0.2ng/mL for warfarin and warfarin alcohols, respectively. The methods were successfully applied to a pooled plasma sample obtained from 69 patients undergoing warfarin therapy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  High performance liquid chromatography; Sample preparation techniques; Warfarin; Warfarin alcohols

Mesh:

Substances:

Year:  2013        PMID: 24054125     DOI: 10.1016/j.chroma.2013.08.091

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Fluorescence Determination of Warfarin Using TGA-capped CdTe Quantum Dots in Human Plasma Samples.

Authors:  A Dehbozorgi; J Tashkhourian; S Zare
Journal:  J Fluoresc       Date:  2015-10-19       Impact factor: 2.217

2.  A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites.

Authors:  Jamil A Haque; Matthew G McDonald; John D Kulman; Allan E Rettie
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

3.  Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid.

Authors:  Tommaso Lomonaco; Silvia Ghimenti; Isabella Piga; Denise Biagini; Massimo Onor; Roger Fuoco; Fabio Di Francesco
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

4.  Impact of posttranslational modifications on atomistic structure of fibrinogen.

Authors:  Žofie Sovová; Jana Štikarová; Jiřina Kaufmanová; Pavel Májek; Jiří Suttnar; Pavel Šácha; Martin Malý; Jan E Dyr
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

5.  Validation of warfarin enantiomer analysis method in plasma using high-performance liquid chromatography fluorescence detector.

Authors:  Norisca Aliza Putriana; Taofik Rusdiana; Tina Rostinawati; Mohammad Rizki Akbar; Febrina Amelia Saputri; Siti Utami
Journal:  J Adv Pharm Technol Res       Date:  2022-01-21

6.  Electromembrane Extraction of Highly Polar Compounds: Analysis of Cardiovascular Biomarkers in Plasma.

Authors:  Nicolas Drouin; Tim Kloots; Julie Schappler; Serge Rudaz; Isabelle Kohler; Amy Harms; Petrus Wilhelmus Lindenburg; Thomas Hankemeier
Journal:  Metabolites       Date:  2019-12-18

7.  Analysis of cholesterol in mouse brain by HPLC with UV detection.

Authors:  María A Paulazo; Alejandro O Sodero
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.